Fox Chase Cancer Center

 

Kidney
15:00

Fox Chase Updates in Bladder and Kidney Cancer 2019

Controversies in Localized RCC: Is Taking a Drug for 12 Months and Being Exposed to AEs Worth Having 12 Months of Clean Scans w/o an OS Impact?

FEATURING Alexander Kutikov
  • 631 views
  • November 22, 2019
  • 3
13:52

Fox Chase Updates in Bladder and Kidney Cancer 2019

Role of Cytoreductive Nephrectomy in mRCC: Acceptable Morbidity Profile, Non-Receipt of Systemic Therapy, Role in IO Era Continues to Evolve

FEATURING Serge Ginzburg
  • 54 views
  • November 22, 2019
22:18

Fox Chase Updates in Bladder and Kidney Cancer 2019

2019 Update on Advanced RCC: Who Needs Treatment, Which 1st Line Drug (Ipi/Nivo, TKI/IO, or TKI Alone), and How to Sequence After 1st Line?

FEATURING Daniel Geynisman
  • 1,548 views
  • December 16, 2019
  • 11
13:28

Fox Chase Updates in Bladder and Kidney Cancer 2019

Kidney Cancer Panel Discussion: Controversies in Localized Disease, Cytoreductive Nephrectomy in mRCC, and Advanced RCC

FEATURING Robert G. Uzzo
  • 43 views
  • November 22, 2019